This market analysis by Technavio segments the global cervical cancer therapeutics market by application (prophylactic vaccines market and therapeutic drugs market), by type of therapy (chemotherapy, targeted therapy, and vaccines), and by geography (APAC, EMEA, and the Americas). Key vendors analyzed in this market study are F. Hoffmann-La Roche, GlaxoSmithKline, and Merck.
Technavio has released updated information on the cancer market, with the publication of its new report, global cervical cancer market. The global cervical cancer therapeutics market is expected to grow at a CAGR of around 5% between 2015 and 2019 due to rising public awareness about vaccines and the dominance of initial screening tests.
The Americas dominate the global market accounting for around 49% of the total market share. The US is predicted to be the highest revenue contributor in the region due to the advent of Avastin targeted therapy and the vaccine Gardasil 9.
Prophylactic vaccines are boosting the growth the cervical cancer therapeutics market accounting for close to 88% of the total market share. The newest prophylactic vaccine, Gardasil 9, and recently approved targeted therapy, Avastin, are expected to prevent approximately 90% of cervical cancer cases.
Segmentation of global cervical cancer therapeutics market
“Awareness campaigns and screening programs have led to the early detection and diagnosis of cervical cancer, through vaccine awareness networks. Several organizations such as Centers for Disease Control and Prevention are providing recommendations and awareness programs associated with cervical cancer screening and vaccinations to underserved women. The market is also witnessing a rise in pharmaceutical enterprises, governments, and NGOs offering patient assistance programs to people who cannot afford treatment for cervical cancer,” says Imran Mushtaq, Lead Analyst, Healthcare, Technavio Research.
Leading vendors in the global cervical cancer therapeutics market are F. Hoffmann-La Roche, GlaxoSmithKline, and Merck. This market is characterized by the presence of some prominent vendors who are expected to dominate this market during the forecast period due to their superior product portfolio. The launch of effective drugs and vaccines like Gardasil 9 is expected to intensify the competition between the vendors.
A more detailed analysis is available in the Technavio report, Global Cervical Cancer Market 2015-2019 – Industry Research Report.
https://www.technavio.com/%3Cp%3E%3Cstrong%3EWe%20can%20customize%20this%…
